Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Effect of somatostatin on meal-induced gastric secretion in duodenal ulcer patients


The effect of somatostatin, a growth hormone release-inhibiting hormone (GH-RIH), on basal and meal-, pentagastrin-, or histamine-stimulated gastric acid and pepsin secretion was studied in six duodenal ulcer patients. Intravenous GH-RIH infused in graded doses ranging from 0.62 to 5.0 μg/kg/hr produced a dose-related inhibition of pentagastrin-induced acid secretion reaching about 15% of control level at the dose of 5.0 μg/kg/hr. Acid inhibition was paralleled by a decrease in the pepsin output and accompanied by a dosedependent reduction in serum growth hormone and insulin levels measured by radio-immunoassay. GH-RIH used in a single dose of 2.5 μg/kg/hr produced about 85% inhibition of acid secretion induced by a meal (measured by intragastric titration) accompanied by a significant decrease in serum gastrin and insulin levels. The effect of GH-RIH on histamine-stimulated secretion was very modest and observed only after stopping the GH-RIH infusion. Thus GH-RIH suppressed acid and pepsin secretion induced by pentagastrin and a meal, and this effect was accompanied by a suppression of serum growth hormone and gastrin levels which may contribute to the inhibition of gastric secretion observed.

This is a preview of subscription content, log in to check access.


  1. 1.

    Creutzfeld W, Arnold R: Hemmung der pentagastrin-induzierten Säuresekretion des Magens beim Menschen durch Somatostatin. Dtsch Med Wochenschr 100:1014–1016, 1975

  2. 2.

    Lankisch PG, Arnold R, Creutzfeld W: Wirkung von Somatostatin auf die betazole-stimulierte Magensekretion und die carbachol-stimulierte Pankreassekretion und Gallenblasenkontraktion des Menschen. Dtsch Med Wochenschr 100:1797–1800, 1975

  3. 3.

    Bloom SR, Mortimer CH, Thorner MO, Besser GM, Hall R, Gomez-Pan A, Roy VM, Russell RCG, Coy DH, Kastin AJ, Schally AV: Inhibition of gastrin and gastric acid secretion by growth hormone release-inhibiting hormone. Lancet 2:1106–1109, 1974

  4. 4.

    Konturek SR, Biernat J, Kwiecień N, Oleksy J: Effect of glucagon on meal-induced gastric secretion in man. Gastroenterology 68:448–454, 1975

  5. 5.

    Northrop JH, Kunitz M, Herrot RM: Crystalline Enzymes, 2nd ed. New York, Columbia University Press, 1948

  6. 6.

    Anson ML: The estimation of pepsin, trypsin, papain and cathepsin with hemoglobin. J Gen Physiol 22:79–80, 1938

  7. 7.

    Fordtran JS, Walsh IR: Gastric acid secretion rate and buffer content of the stomach after eating; Results in normal subjects and in patients with duodenal ulcer. J Clin Invest 52:645–657, 1973

  8. 8.

    Grossman MI, Marks IN: Secretion of pepsinogen by the pyloric glands of the dog, with some observations on the histology of the gastric mucosa. Gastroenterology 38:342–352, 1960

  9. 9.

    Yalow RS, Berson SA: Radioimmunoassay of gastrin. Gastroenterology 58:1–14, 1970

  10. 10.

    Schalch DS, Parker ML: A sensitive double antibody immunoassay for human growth hormone in plasma. Nature 203:1141–1142, 1964

  11. 11.

    Herbert V, Lan KS, Gottlieb CW: Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:1375–1384, 1965

  12. 12.

    Reinhold JG: Glucose, Standard Methods of Clinical Chemistry. Part I. Baltimore, Williams and Wilkins, 1953

  13. 13.

    Snedecor GM: Statistical Methods. University Press, Ames, Iowa, 1957

  14. 14.

    Barros D'Sa AAJ, Bloom RS, Baron JH: Direct inhibition of gastric acid by growth-hormone release-inhibiting hormone in dogs. Lancet 1:886–887, 1975

  15. 15.

    Konturek SJ, Tasler J, Cieszkowski M, Coy DH, Schally AV: Effect of growth hormone release-inhibiting hormone on gastric secretion, mucosal blood flow and serum gastrin. Gastroenterology 70:737–741, 1976

  16. 16.

    Enochs MR, Johnson LR: Effect of hypophysectomy and growth hormone on serum and antral gastrin. Fed Proc 34:411, 1975

  17. 17.

    Johnson LR: The trophic action of gastrointestinal hormones. Gastroenterology 70:278–288, 1976

  18. 18.

    Arimura A, Sato H, Dupont A, Nishi N, Schally AV: Abundance of immunoreactive GH-release inhibiting hormone in the stomach and the pancreas of rat. Fed Proc 34:273, 1975

  19. 19.

    Konturek SJ: Somatostatin and the gastrointestinal secretions. Scand J Gastroenterol 11:1–4, 1976

  20. 20.

    Wingate D: The eupeptide system; a general theory of gastrointestinal hormones. Lancet 1:529–532, 1976

  21. 21.

    Besser GM, Paxton AM, Johnson SAN, Moody EJ, Mortimer CH, Hall R, Gomez-Pan A, Schally AV, Kastin AJ, Coy DH: Impairment of platelets function by growth-hormone release-inhibiting hormone. Lancet 1:1166–1168, 1975

  22. 22.

    Mattes P, Raptis S, Heil T, Rasche H, Scheck R: Extended somatostatin treatment of a patient with bleeding ulcer. Horm Metab Res 7:507–512, 1975

Download references

Author information

Correspondence to Dr. S. J. Konturek MD.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Konturek, S.J., Świerczek, J., Kwiecień, N. et al. Effect of somatostatin on meal-induced gastric secretion in duodenal ulcer patients. Digest Dis Sci 22, 981–988 (1977). https://doi.org/10.1007/BF01076197

Download citation


  • Growth Hormone
  • Gastric Acid
  • Insulin Level
  • Duodenal Ulcer
  • Acid Secretion